الفهرس 
Low Grade LymphomaOnly 14 pages are availabe for public view
 |  | from | 114 |  |  |
| | | from | 114 | | |
Abstract
Conclusion: This study suggest that the BCMA level is significantly higher in patients with iNHL than the healthy controls. By increasing the Age ≥ 40 years the risk of iNHL is increased by 1.71 folds than otherwise healthy controls. The BCMA level was positively correlated to LDH implying that BCMA could be related to iNHL proliferation rate and possibly lymphoma aggressiveness. The level of BCMA more than 430 ng/dL correlated with a more than a 4.5-fold rise in the risk of higher disease stage with borderline significance. Furthter studies are needed to detect the relation between The BCMA level and the disease prognosis that may be useful for a promising AntiBCMA targeted therapy for RR patients.